{"id":"https://openalex.org/W4401217299","doi":"https://doi.org/10.1002/jha2.968","title":"A phase 1b/2 study evaluating efficacy and safety of MP0250, a designed ankyrin repeat protein (DARPin) simultaneously targeting vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF), in combination with bortezomib and dexamethasone, in patients with relapsed or refractory multiple myeloma","display_name":"A phase 1b/2 study evaluating efficacy and safety of MP0250, a designed ankyrin repeat protein (DARPin) simultaneously targeting vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF), in combination with bortezomib and dexamethasone, in patients with relapsed or refractory multiple myeloma","publication_year":2024,"publication_date":"2024-08-01","ids":{"openalex":"https://openalex.org/W4401217299","doi":"https://doi.org/10.1002/jha2.968","pmid":"https://pubmed.ncbi.nlm.nih.gov/39415900","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/11474421"},"language":"en","primary_location":{"id":"doi:10.1002/jha2.968","doi":"https://doi.org/10.1002/jha2.968","is_oa":true,"landing_page_url":"https://doi.org/10.1002/jha2.968","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jha2.968","source":{"id":"https://openalex.org/S4210227740","display_name":"eJHaem","issn_l":"2688-6146","issn":["2688-6146"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-1","oarl"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"eJHaem","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jha2.968","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026611811","display_name":"Stefan Tobias Knop","orcid":"https://orcid.org/0000-0003-1276-6639","observed_orcids":["https://orcid.org/0000-0003-1276-6639"]},"institutions":[{"id":"https://openalex.org/I4210126310","display_name":"Universit\u00e4tsklinikum W\u00fcrzburg","ror":"https://ror.org/03pvr2g57","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210126310"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Stefan Knop","raw_affiliation_strings":["Universit\u00e4tsklinikum W\u00fcrzburg  W\u00fcrzburg Germany"],"raw_orcid":"https://orcid.org/0000-0003-1276-6639","affiliations":[{"raw_affiliation_string":"Universit\u00e4tsklinikum W\u00fcrzburg  W\u00fcrzburg Germany","institution_ids":["https://openalex.org/I4210126310"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078222722","display_name":"Monika Szarejko","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131945","display_name":"University Clinical Centre","ror":"https://ror.org/02kyzv273","country_code":"PL","type":"healthcare","lineage":["https://openalex.org/I4210131945"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Monika Szarejko","raw_affiliation_strings":["Uniwersyteckie Centrum Kliniczne, Gdansk, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Uniwersyteckie Centrum Kliniczne, Gdansk, Poland","institution_ids":["https://openalex.org/I4210131945"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023457611","display_name":"Norbert Grz\u0105\u015bko","orcid":"https://orcid.org/0000-0001-7727-4307","observed_orcids":["https://orcid.org/0000-0001-7727-4307"]},"institutions":[{"id":"https://openalex.org/I121032520","display_name":"Medical University of Lublin","ror":"https://ror.org/016f61126","country_code":"PL","type":"education","lineage":["https://openalex.org/I121032520"]},{"id":"https://openalex.org/I4210125819","display_name":"Lublin Oncology Center","ror":"https://ror.org/03a02sz29","country_code":"PL","type":"facility","lineage":["https://openalex.org/I4210125819"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Norbert Grz\u0105\u015bko","raw_affiliation_strings":["Department of Experimental Hematooncology, Medical University of Lublin and Centrum Onkologii Ziemi Lubelskiej, Lublin, Poland"],"raw_orcid":"https://orcid.org/0000-0001-7727-4307","affiliations":[{"raw_affiliation_string":"Department of Experimental Hematooncology, Medical University of Lublin and Centrum Onkologii Ziemi Lubelskiej, Lublin, Poland","institution_ids":["https://openalex.org/I121032520","https://openalex.org/I4210125819"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067110512","display_name":"Sara Bringhen","orcid":"https://orcid.org/0000-0003-4539-6363","observed_orcids":["https://orcid.org/0000-0003-4539-6363"]},"institutions":[{"id":"https://openalex.org/I4210086903","display_name":"Azienda Ospedaliera Citta' della Salute e della Scienza di Torino","ror":"https://ror.org/001f7a930","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210086903"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Sara Bringhen","raw_affiliation_strings":["SSD Clinical Trial in Oncoematologia e Myeloma, Dipartimento di Oncologia Azienda Ospedaliera\u2010Universitaria Citt\u00e0 della Salute e della Scienza di Torino Torino Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SSD Clinical Trial in Oncoematologia e Myeloma, Dipartimento di Oncologia Azienda Ospedaliera\u2010Universitaria Citt\u00e0 della Salute e della Scienza di Torino Torino Italy","institution_ids":["https://openalex.org/I4210086903"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018230264","display_name":"Karolin Trautmann\u2010Grill","orcid":"https://orcid.org/0000-0002-9050-1049","observed_orcids":["https://orcid.org/0000-0002-9050-1049"]},"institutions":[{"id":"https://openalex.org/I78650965","display_name":"Technische Universit\u00e4t Dresden","ror":"https://ror.org/042aqky30","country_code":"DE","type":"education","lineage":["https://openalex.org/I78650965"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Karolin Trautmann\u2010Grill","raw_affiliation_strings":["Universit\u00e4tsklinikum Dresden, Technische Universit\u00e4t Dresden  Dresden Germany"],"raw_orcid":"https://orcid.org/0000-0002-9050-1049","affiliations":[{"raw_affiliation_string":"Universit\u00e4tsklinikum Dresden, Technische Universit\u00e4t Dresden  Dresden Germany","institution_ids":["https://openalex.org/I78650965"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046942962","display_name":"Artur J. Jurczyszyn","orcid":"https://orcid.org/0000-0001-9796-8365","observed_orcids":["https://orcid.org/0000-0001-9796-8365"]},"institutions":[{"id":"https://openalex.org/I126596746","display_name":"Jagiellonian University","ror":"https://ror.org/03bqmcz70","country_code":"PL","type":"education","lineage":["https://openalex.org/I126596746"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Artur Jurczyszyn","raw_affiliation_strings":["Plasma Cell Dyscrasias Center, Department of Hematology, Jagiellonian University Medical College, Krakow, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Plasma Cell Dyscrasias Center, Department of Hematology, Jagiellonian University Medical College, Krakow, Poland","institution_ids":["https://openalex.org/I126596746"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012195468","display_name":"Angelo Vacca","orcid":"https://orcid.org/0000-0002-4567-8216","observed_orcids":["https://orcid.org/0000-0002-4567-8216"]},"institutions":[{"id":"https://openalex.org/I4210095088","display_name":"Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari","ror":"https://ror.org/00pap0267","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210095088","https://openalex.org/I4210099368","https://openalex.org/I4210117053"]},{"id":"https://openalex.org/I5561750","display_name":"University of Bari Aldo Moro","ror":"https://ror.org/027ynra39","country_code":"IT","type":"education","lineage":["https://openalex.org/I5561750"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Angelo Vacca","raw_affiliation_strings":["Department of Precision and Regenerative Medicine and Ionian Area Unit of Medicina Interna \"Guido Baccelli\", University of Bari Aldo Moro, Azienda Policlinico, Bari, Italy"],"raw_orcid":"https://orcid.org/0000-0002-4567-8216","affiliations":[{"raw_affiliation_string":"Department of Precision and Regenerative Medicine and Ionian Area Unit of Medicina Interna \"Guido Baccelli\", University of Bari Aldo Moro, Azienda Policlinico, Bari, Italy","institution_ids":["https://openalex.org/I4210095088","https://openalex.org/I5561750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048727363","display_name":"Cyrus Khandanpour","orcid":"https://orcid.org/0000-0003-4655-6269","observed_orcids":["https://orcid.org/0000-0003-4655-6269"]},"institutions":[{"id":"https://openalex.org/I4210103666","display_name":"University Hospital M\u00fcnster","ror":"https://ror.org/01856cw59","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210103666"]},{"id":"https://openalex.org/I4210112713","display_name":"University Hospital Schleswig-Holstein","ror":"https://ror.org/01tvm6f46","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210112713"]},{"id":"https://openalex.org/I9341345","display_name":"University of L\u00fcbeck","ror":"https://ror.org/00t3r8h32","country_code":"DE","type":"education","lineage":["https://openalex.org/I9341345"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Cyrus Khandanpour","raw_affiliation_strings":["Universit\u00e4tsklinikum M\u00fcnster, M\u00fcnster, Germany and University Hospital Schleswig\u2010Holstein Campus L\u00fcbeck University Cancer Center Schleswig\u2010Holstein, and University of L\u00fcbeck L\u00fcbeck Germany"],"raw_orcid":"https://orcid.org/0000-0003-4655-6269","affiliations":[{"raw_affiliation_string":"Universit\u00e4tsklinikum M\u00fcnster, M\u00fcnster, Germany and University Hospital Schleswig\u2010Holstein Campus L\u00fcbeck University Cancer Center Schleswig\u2010Holstein, and University of L\u00fcbeck L\u00fcbeck Germany","institution_ids":["https://openalex.org/I4210103666","https://openalex.org/I4210112713","https://openalex.org/I9341345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051231544","display_name":"Barbara Gamberi","orcid":"https://orcid.org/0000-0003-3616-5838","observed_orcids":["https://orcid.org/0000-0003-3616-5838"]},"institutions":[{"id":"https://openalex.org/I4210090508","display_name":"Azienda Sanitaria Unit\u00e0 Locale di Reggio Emilia","ror":"https://ror.org/001bbwj30","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210090508"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Barbara Gamberi","raw_affiliation_strings":["AUSL-IRCCS Reggio Emilia, Reggio Emilia, Italy"],"raw_orcid":"https://orcid.org/0000-0003-3616-5838","affiliations":[{"raw_affiliation_string":"AUSL-IRCCS Reggio Emilia, Reggio Emilia, Italy","institution_ids":["https://openalex.org/I4210090508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109656080","display_name":"Lud\u011bk Pour","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210102302","display_name":"University Hospital Brno","ror":"https://ror.org/00qq1fp34","country_code":"CZ","type":"healthcare","lineage":["https://openalex.org/I4210102302"]}],"countries":["CZ"],"is_corresponding":false,"raw_author_name":"Ludek Pour","raw_affiliation_strings":["Fakultn\u00ed Nemocnice Brno Brno Czechia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fakultn\u00ed Nemocnice Brno Brno Czechia","institution_ids":["https://openalex.org/I4210102302"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000943471","display_name":"Katrine Fladeland Iversen","orcid":"https://orcid.org/0000-0003-4494-9034","observed_orcids":["https://orcid.org/0000-0003-4494-9034"]},"institutions":[{"id":"https://openalex.org/I4210142184","display_name":"Lillebaelt Hospital","ror":"https://ror.org/04jewc589","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I4210142184"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Katrine F. Iversen","raw_affiliation_strings":["Lillebaelt Hospital, Vejle, Denmark"],"raw_orcid":"https://orcid.org/0000-0003-4494-9034","affiliations":[{"raw_affiliation_string":"Lillebaelt Hospital, Vejle, Denmark","institution_ids":["https://openalex.org/I4210142184"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027692708","display_name":"Michael Tobias Stumpp","orcid":"https://orcid.org/0000-0001-7356-2061","observed_orcids":["https://orcid.org/0000-0001-7356-2061"]},"institutions":[{"id":"https://openalex.org/I4210103213","display_name":"Molecular Partners (Switzerland)","ror":"https://ror.org/00tebjn14","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210103213"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Michael T. Stumpp","raw_affiliation_strings":["Molecular Partners AG, Zurich-Schlieren, Switzerland"],"raw_orcid":"https://orcid.org/0000-0001-7356-2061","affiliations":[{"raw_affiliation_string":"Molecular Partners AG, Zurich-Schlieren, Switzerland","institution_ids":["https://openalex.org/I4210103213"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108241667","display_name":"Cosima Suter","orcid":"https://orcid.org/0000-0002-7657-1382","observed_orcids":["https://orcid.org/0000-0002-7657-1382"]},"institutions":[{"id":"https://openalex.org/I4210103213","display_name":"Molecular Partners (Switzerland)","ror":"https://ror.org/00tebjn14","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210103213"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Cosima Suter","raw_affiliation_strings":["Molecular Partners AG, Zurich-Schlieren, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Partners AG, Zurich-Schlieren, Switzerland","institution_ids":["https://openalex.org/I4210103213"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082661914","display_name":"Keith Martin Dawson","orcid":"https://orcid.org/0000-0002-1770-291X","observed_orcids":["https://orcid.org/0000-0002-1770-291X"]},"institutions":[{"id":"https://openalex.org/I4210103213","display_name":"Molecular Partners (Switzerland)","ror":"https://ror.org/00tebjn14","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210103213"]}],"countries":["CH"],"is_corresponding":true,"raw_author_name":"Keith M. Dawson","raw_affiliation_strings":["Molecular Partners AG, Zurich-Schlieren, Switzerland"],"raw_orcid":"https://orcid.org/0000-0002-1770-291X","affiliations":[{"raw_affiliation_string":"Molecular Partners AG, Zurich-Schlieren, Switzerland","institution_ids":["https://openalex.org/I4210103213"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017141570","display_name":"Christof Zitt","orcid":"https://orcid.org/0009-0000-9359-6891","observed_orcids":["https://orcid.org/0009-0000-9359-6891"]},"institutions":[{"id":"https://openalex.org/I4210103213","display_name":"Molecular Partners (Switzerland)","ror":"https://ror.org/00tebjn14","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210103213"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Christof Zitt","raw_affiliation_strings":["Molecular Partners AG, Zurich-Schlieren, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Partners AG, Zurich-Schlieren, Switzerland","institution_ids":["https://openalex.org/I4210103213"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006279159","display_name":"Philippe Legenne","orcid":"https://orcid.org/0009-0005-6586-1447","observed_orcids":["https://orcid.org/0009-0005-6586-1447"]},"institutions":[{"id":"https://openalex.org/I4210103213","display_name":"Molecular Partners (Switzerland)","ror":"https://ror.org/00tebjn14","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210103213"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Philippe Legenne","raw_affiliation_strings":["Molecular Partners AG, Zurich-Schlieren, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Partners AG, Zurich-Schlieren, Switzerland","institution_ids":["https://openalex.org/I4210103213"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027733991","display_name":"Vaia Stavropoulou","orcid":"https://orcid.org/0000-0002-3000-2205","observed_orcids":["https://orcid.org/0000-0002-3000-2205"]},"institutions":[{"id":"https://openalex.org/I4210103213","display_name":"Molecular Partners (Switzerland)","ror":"https://ror.org/00tebjn14","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210103213"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Vaia Stavropoulou","raw_affiliation_strings":["Molecular Partners AG, Zurich-Schlieren, Switzerland"],"raw_orcid":"https://orcid.org/0000-0002-3000-2205","affiliations":[{"raw_affiliation_string":"Molecular Partners AG, Zurich-Schlieren, Switzerland","institution_ids":["https://openalex.org/I4210103213"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110137995","display_name":"Martin F. Fey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210103213","display_name":"Molecular Partners (Switzerland)","ror":"https://ror.org/00tebjn14","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210103213"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Martin F. Fey","raw_affiliation_strings":["Molecular Partners AG, Zurich-Schlieren, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Partners AG, Zurich-Schlieren, Switzerland","institution_ids":["https://openalex.org/I4210103213"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011625621","display_name":"Nicolas Leupin","orcid":"https://orcid.org/0009-0003-3114-9940","observed_orcids":["https://orcid.org/0009-0003-3114-9940"]},"institutions":[{"id":"https://openalex.org/I4210103213","display_name":"Molecular Partners (Switzerland)","ror":"https://ror.org/00tebjn14","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210103213"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Nicolas Leupin","raw_affiliation_strings":["Molecular Partners AG, Zurich-Schlieren, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Partners AG, Zurich-Schlieren, Switzerland","institution_ids":["https://openalex.org/I4210103213"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5055916434","display_name":"Hartmut Goldschmidt","orcid":"https://orcid.org/0000-0003-0961-0035","observed_orcids":["https://orcid.org/0000-0003-0961-0035"]},"institutions":[{"id":"https://openalex.org/I2802164966","display_name":"University Hospital Heidelberg","ror":"https://ror.org/013czdx64","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2802164966"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Hartmut Goldschmidt","raw_affiliation_strings":["Medical Department V Universit\u00e4tsklinikum Heidelberg  Heidelberg Germany"],"raw_orcid":"https://orcid.org/0000-0003-0961-0035","affiliations":[{"raw_affiliation_string":"Medical Department V Universit\u00e4tsklinikum Heidelberg  Heidelberg Germany","institution_ids":["https://openalex.org/I2802164966"]}]}],"institutions":[],"countries_distinct_count":6,"institutions_distinct_count":17,"corresponding_author_ids":["https://openalex.org/A5082661914"],"corresponding_institution_ids":["https://openalex.org/I4210103213"],"apc_list":{"value":2600,"currency":"USD","value_usd":2600},"apc_paid":{"value":2600,"currency":"USD","value_usd":2600},"fwci":2.7804,"has_fulltext":true,"cited_by_count":10,"citation_normalized_percentile":{"value":0.90611135,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":97,"max":98},"biblio":{"volume":"5","issue":"5","first_page":"940","last_page":"950"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/designed-ankyrin-repeat-proteins","display_name":"DARPin","score":0.9430000185966492},{"id":"https://openalex.org/keywords/vegf-a","display_name":"VEGF-A","score":0.7789999842643738},{"id":"https://openalex.org/keywords/hepatocyte-growth-factor","display_name":"hepatocyte growth factor","score":0.9929999709129333},{"id":"https://openalex.org/keywords/relapsed-refractory-multiple-myeloma","display_name":"relapsed/refractory multiple myeloma","score":0.9520000219345093},{"id":"https://openalex.org/keywords/bortezomib","display_name":"bortezomib","score":0.9739999771118164},{"id":"https://openalex.org/keywords/dexamethasone","display_name":"dexamethasone","score":0.9990000128746033},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.8209999799728394},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.925000011920929},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.6460000276565552},{"id":"https://openalex.org/keywords/thrombocytopenia","display_name":"thrombocytopenia","score":0.8799999952316284},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.7139999866485596},{"id":"https://openalex.org/keywords/treatment-related-adverse-events","display_name":"treatment-related adverse events","score":0.46700000762939453}],"concepts":[{"id":"https://openalex.org/C2777478702","wikidata":"https://www.wikidata.org/wiki/Q419319","display_name":"Bortezomib","level":3,"score":0.7485619783401489},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7304447889328003},{"id":"https://openalex.org/C2777025900","wikidata":"https://www.wikidata.org/wiki/Q29725","display_name":"Vascular endothelial growth factor","level":3,"score":0.6067208051681519},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5855879187583923},{"id":"https://openalex.org/C2776996007","wikidata":"https://www.wikidata.org/wiki/Q2399112","display_name":"Hepatocyte growth factor","level":3,"score":0.5632629990577698},{"id":"https://openalex.org/C2778367456","wikidata":"https://www.wikidata.org/wiki/Q7251235","display_name":"Proteasome inhibitor","level":3,"score":0.506381630897522},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4802670478820801},{"id":"https://openalex.org/C2779984678","wikidata":"https://www.wikidata.org/wiki/Q2145898","display_name":"Response Evaluation Criteria in Solid Tumors","level":4,"score":0.46787306666374207},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4668719470500946},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4520816206932068},{"id":"https://openalex.org/C2779561371","wikidata":"https://www.wikidata.org/wiki/Q570197","display_name":"Proteinuria","level":3,"score":0.427133709192276},{"id":"https://openalex.org/C128057223","wikidata":"https://www.wikidata.org/wiki/Q420566","display_name":"Calcineurin","level":3,"score":0.4266747832298279},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.389227956533432},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.3478120267391205},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.33615970611572266},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.2486102283000946},{"id":"https://openalex.org/C167734588","wikidata":"https://www.wikidata.org/wiki/Q4356503","display_name":"VEGF receptors","level":2,"score":0.07788851857185364},{"id":"https://openalex.org/C2780091579","wikidata":"https://www.wikidata.org/wiki/Q9377","display_name":"Kidney","level":2,"score":0.07666945457458496},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[],"locations_count":6,"locations":[{"id":"doi:10.1002/jha2.968","doi":"https://doi.org/10.1002/jha2.968","is_oa":true,"landing_page_url":"https://doi.org/10.1002/jha2.968","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jha2.968","source":{"id":"https://openalex.org/S4210227740","display_name":"eJHaem","issn_l":"2688-6146","issn":["2688-6146"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-1","oarl"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"eJHaem","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:11474421","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11474421","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11474421/pdf/JHA2-5-940.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"EJHaem","raw_type":"Text"},{"id":"pmid:39415900","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/39415900","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"EJHaem","raw_type":"Journal Article"},{"id":"pmh:oai:ruj.uj.edu.pl:item/499736","doi":null,"is_oa":true,"landing_page_url":"https://ruj.uj.edu.pl/handle/item/499736","pdf_url":"http://ruj.uj.edu.pl/bitstreams/695761ac-9009-4572-b3ea-1b2fa9e640b1/download","source":{"id":"https://openalex.org/S4306401249","display_name":"Jagiellonian University Repository (Jagiellonian University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I126596746","host_organization_name":"Jagiellonian University","host_organization_lineage":["https://openalex.org/I126596746"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:sdu.dk:openaire/be37700a-4a58-478f-9876-8f22b6fefa23","doi":null,"is_oa":true,"landing_page_url":"https://portal.findresearcher.sdu.dk/da/publications/be37700a-4a58-478f-9876-8f22b6fefa23","pdf_url":"https://findresearcher.sdu.dk/ws/files/275479793/eJHaem_-_2024_-_Knop_-_A_phase_1b_2_study_evaluating_efficacy_and_safety_of_MP0250_a_designed_ankyrin_repeat_protein_.pdf","source":{"id":"https://openalex.org/S4306400423","display_name":"University of Southern Denmark Research Portal (University of Southern Denmark)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I177969490","host_organization_name":"University of Southern Denmark","host_organization_lineage":["https://openalex.org/I177969490"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:doaj.org/article:d9320941c5f7443ea0d680430869e3d7","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/d9320941c5f7443ea0d680430869e3d7","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"eJHaem, Vol 5, Iss 5, Pp 940-950 (2024)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1002/jha2.968","doi":"https://doi.org/10.1002/jha2.968","is_oa":true,"landing_page_url":"https://doi.org/10.1002/jha2.968","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jha2.968","source":{"id":"https://openalex.org/S4210227740","display_name":"eJHaem","issn_l":"2688-6146","issn":["2688-6146"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-1","oarl"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"eJHaem","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4401217299.pdf","grobid_xml":"https://content.openalex.org/works/W4401217299.grobid-xml"},"referenced_works_count":35,"referenced_works":["https://openalex.org/W1501068977","https://openalex.org/W1783306815","https://openalex.org/W2000763979","https://openalex.org/W2003734726","https://openalex.org/W2007513598","https://openalex.org/W2018890642","https://openalex.org/W2031692900","https://openalex.org/W2040272160","https://openalex.org/W2147486721","https://openalex.org/W2157964886","https://openalex.org/W2164435768","https://openalex.org/W2171568102","https://openalex.org/W2560353175","https://openalex.org/W2600415211","https://openalex.org/W2762221910","https://openalex.org/W2765289319","https://openalex.org/W2783782130","https://openalex.org/W2791152679","https://openalex.org/W3025151981","https://openalex.org/W3034116776","https://openalex.org/W3037917943","https://openalex.org/W3113161443","https://openalex.org/W3118929592","https://openalex.org/W3211334758","https://openalex.org/W4206956920","https://openalex.org/W4302759581","https://openalex.org/W4313643480","https://openalex.org/W4323035289","https://openalex.org/W4379341229","https://openalex.org/W4384282063","https://openalex.org/W4386219363","https://openalex.org/W4386271388","https://openalex.org/W4386755094","https://openalex.org/W4387662079","https://openalex.org/W4392792022"],"related_works":["https://openalex.org/W2763416544","https://openalex.org/W2985534729","https://openalex.org/W2915861299","https://openalex.org/W2599888622","https://openalex.org/W3113161443","https://openalex.org/W2890809248","https://openalex.org/W2589074231","https://openalex.org/W2406566128","https://openalex.org/W2068331698","https://openalex.org/W4409446649"],"abstract_inverted_index":{"MP0250":[0,40,55,84,223],"is":[1],"a":[2,35,154],"designed":[3],"ankyrin":[4],"repeat":[5],"protein":[6],"that":[7],"specifically":[8],"inhibits":[9],"both":[10,54],"vascular":[11],"endothelial":[12],"growth":[13,19],"factor":[14,20],"A":[15],"(VEGF-A)":[16],"and":[17,117,172,209],"hepatocyte":[18],"(HGF),":[21],"aiming":[22],"at":[23,97,135],"potentiating":[24],"cancer":[25],"therapy":[26],"by":[27],"disrupting":[28],"the":[29,122,177,197,232,242],"tumour":[30],"microenvironment.":[31],"Encouraging":[32],"results":[33,198],"from":[34],"phase":[36,69],"1":[37],"trial":[38],"of":[39,62,101,145,157,159,199,213,245],"in":[41,49,73,194,224,231],"patients":[42,74,95,124,168,217],"with":[43,75,90,153,196,218,222,226],"solid":[44],"tumours":[45],"prompted":[46],"further":[47],"investigation":[48],"multiple":[50],"myeloma":[51],"(MM)":[52],"as":[53,176],"targets":[56],"are":[57,193],"reported":[58],"to":[59,140,240],"be":[60,238],"drivers":[61],"MM":[63,220,234],"pathogenesis.":[64],"In":[65],"this":[66],"open-label,":[67],"single-arm":[68],"1b/2":[70],"study":[71],"(NCT03136653)":[72],"proteasome":[76],"inhibitor-":[77],"and/or":[78],"immunomodulatory":[79],"drug-relapsed":[80],"or":[81],"refractory":[82],"MM,":[83],"was":[85,185],"administered":[86],"every":[87],"3":[88],"weeks":[89],"standard":[91],"bortezomib/dexamethasone":[92],"regimen.":[93],"Thirty-three":[94],"received":[96],"least":[98,136],"one":[99],"dose":[100],"MP0250.":[102,246],"The":[103],"most":[104],"frequent":[105],"treatment-related":[106],"adverse":[107],"events":[108],"were":[109],"arterial":[110],"hypertension":[111],"(58.1%),":[112],"thrombocytopenia":[113],"(32.3%),":[114],"proteinuria":[115],"(29.0%)":[116],"peripheral":[118],"oedema":[119],"(19.4%).":[120],"Of":[121],"28":[123],"evaluable":[125],"for":[126,216],"response":[127,143,158,171],"(median":[128],"age:":[129],"60":[130],"[range":[131],"44-75]),":[132],"nine":[133,173],"achieved":[134,169],"partial":[137],"response,":[138],"corresponding":[139],"an":[141],"overall":[142,179],"rate":[144],"32.1%":[146],"(95%":[147,162,188],"confidence":[148],"interval":[149],"[CI]:":[150],"17.9%,":[151],"50.7%),":[152],"median":[155,182],"duration":[156],"8":[160],"months":[161,187],"CI":[163,189],"5-NR).":[164],"An":[165],"additional":[166],"three":[167],"minimal":[170],"stable":[174],"diseases":[175],"best":[178],"response.":[180],"Overall":[181],"progression-free":[183],"survival":[184],"4.2":[186],"1.9-7.1).":[190],"These":[191],"findings":[192],"line":[195],"recent":[200],"trials":[201],"testing":[202],"new":[203],"agents":[204],"on":[205],"comparable":[206],"patient":[207],"cohorts":[208],"provide":[210],"initial":[211],"evidence":[212],"clinical":[214,229,243],"benefit":[215],"refractory/relapsed":[219],"treated":[221],"combination":[225],"bortezomib/dexamethasone.":[227],"Further":[228],"evaluation":[230],"emerging":[233],"treatment":[235],"landscape":[236],"would":[237],"required":[239],"confirm":[241],"potential":[244]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":6}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2024-08-02T00:00:00"}